Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 19, 2022
Performance assessment of the new Xpert® HIV-1 viral load XC assay for quantification of HIV-1 viral loadsRobert Ehret, Kudor Harb, Stefan Breuer, et al.Microbiology Spectrum|March 10, 2026
Analytical and clinical evaluation of the Alinity m Resp-4-Plex assay in comparison to two singleplex SARS-CoV-2 assays and one multiplex respiratory assayRobert Ehret, Malik Prentice, Birgit Reinhardt, et al.Journal of Virological Methods|October 25, 2021
Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assaysRobert Ehret, Stefan Breuer, Jens Dhein, et al.Journal of the International AIDS Society|November 15, 2014
Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratoryRobert Ehret, Stefan Neifer, Hauke Walter, et al.Journal of the International AIDS Society|November 14, 2014
Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatmentRobert Ehret, Hauke Walter, Patrick Ingiliz, et al.Journal of the International AIDS Society|November 15, 2014
Resistance remains a problem in treatment failureMartin Obermeier, Robert Ehret, Andreas Wienbreyer, et al.Medical Microbiology and Immunology|June 16, 2012
Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremiaGudrun Naeth, Robert Ehret, Frank Wiesmann, et al.Journal of the International AIDS Society|November 15, 2014
New dolutegravir resistance pattern identified in a patient failing antiretroviral therapyAndreas Carganico, Stefan Dupke, Robert Ehret, et al.Clinical Chemistry and Laboratory Medicine|January 25, 2007
Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routinePatrick Braun, Robert Ehret, Frank Wiesmann, et al.Medical Microbiology and Immunology|February 22, 2017
HIV-1 persistent viremia is frequently followed by episodes of low-level viremiaMarek Widera, Miriam Dirks, Barbara Bleekmann, et al.Pageof 3